New study solves an arthritis drug mystery
MIT biological engineers discover why a promising drug failed in clinical trials.
MIT biological engineers discover why a promising drug failed in clinical trials.
New cancer research initiative eyes individualized treatment for patients.
Platform connects individual pieces of lab equipment, compiles data in the cloud for speedier, more accurate research.
Replacing daily pills with a weekly regimen could help patients stick to their dosing schedule.
Continuous-flow chemistry device used for drug production could find use in long-duration space missions.
NEWDIGS Initiative at MIT leads multi-stakeholder collaboration to design and pilot a sustainable, patient-centered innovation ecosystem for a target disease.
New strategy could enable existing drugs to kill bacteria that cause chronic infections.
Industry leaders, patient advocates, and policymakers collaborate to make groundbreaking new therapies economically sustainable.
Studies by Richard Wurtman have led to development of nutrient mix shown to slow cognitive impairment in early stages of the disease.
Microparticles created by new 3-D fabrication method could release drugs or vaccines long after injection.
MIT affiliates recognized for their innovative approaches to energy storage and drug discovery.
Study finds bacterial response to drugs varies in different environments.
In study that may guide drug design, researchers find organelles encounter varying levels of resistance.
Honor recognizes bioengineer’s advance of analytical techniques for characterization of biopharmaceuticals.
Entrepreneurs, researchers, and industry experts build connections at workshop.